Related Experiment Video
Updated: May 29, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Insights
This genome-wide association study identified 16 new genetic regions influencing blood pressure. A genetic risk score linked these variants to hypertension and cardiovascular diseases.
Area of Science:
- Genetics
- Cardiovascular Physiology
- Public Health
Background:
- Hypertension affects over one billion people globally.
- Elevated blood pressure increases cardiovascular event risk.
- Blood pressure is a heritable trait influenced by genetics and environment.
Purpose of the Study:
- To identify novel genetic loci associated with blood pressure.
- To investigate the genetic risk score's association with hypertension and related conditions.
- To explore blood pressure genetics across diverse ancestries.
Main Methods:
- Multi-stage genome-wide association study (GWAS) in 200,000 European individuals.
- Analysis of systolic and diastolic blood pressure.
- Development and validation of a genetic risk score using 29 variants.
Main Results:
- Identified 16 novel genetic loci influencing blood pressure.
- Six loci contained known blood pressure regulatory genes; ten provided new insights.
- Genetic risk score associated with hypertension, left ventricular wall thickness, stroke, and coronary artery disease.
- Observed cross-ancestry associations with blood pressure.
Conclusions:
- New insights into blood pressure genetics and physiology.
- Potential for novel therapeutic targets for cardiovascular disease prevention.
- Genetic risk score is a significant predictor of hypertension and cardiovascular outcomes.
Abstract:
Blood pressure is a heritable trait influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have hypertension (≥140 mm Hg systolic blood pressure or ≥90 mm Hg diastolic blood pressure). Even small increments in blood pressure are associated with an increased risk of cardiovascular events. This genome-wide association study of systolic and diastolic blood pressure, which used a multi-stage design in 200,000 individuals of European descent, identified sixteen novel loci: six of these loci contain genes previously known or suspected to regulate blood pressure (GUCY1A3-GUCY1B3, NPR3-C5orf23, ADM, FURIN-FES, GOSR2, GNAS-EDN3); the other ten provide new clues to blood pressure physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function. We also observed associations with blood pressure in East Asian, South Asian and African ancestry individuals. Our findings provide new insights into the genetics and biology of blood pressure, and suggest potential novel therapeutic pathways for cardiovascular disease prevention.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease I: Introduction
